Journal
HELIYON
Volume 8, Issue 9, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.heliyon.2022.e10365
Keywords
Stem cells; Heart; Cardiac organoids; iPSCs; Disease modelling; Toxicity screening; Drug screening; Cell culture; Pharmacology
Categories
Funding
- Free State of Saxony
- European Union
- Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [288034826 - IRTG 2251]
Ask authors/readers for more resources
The combination of hiPSC and organoid technology allows the generation of 3D human culture systems, providing a means to model human tissue-like structures in vitro. This protocol provides detailed instructions to efficiently generate and characterize self-assembling 3D cardiac organoids using hiPSC-derived cardiomyocytes. Cardiac organoids can serve as 3D-based assay systems with various applications in pharmacological and toxicological research, offering an alternative to animal experiments.
The combination of the human induced pluripotent stem cell (hiPSC) and organoid technology enables the generation of human 3D culture systems, providing the opportunity to model human tissue-like structures in vitro. This protocol offers the details to generate and characterize self-assembling 3D cardiac organoids in a controlled and efficient manner based on hiPSC-derived cardiomyocytes. Cardiac organoids can be used as 3D-based assay systems and offer a wide range of applications in pharmacological and toxicological research as well as an alternative to animal experiments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available